Penumbra, Inc. Common Stock (NY:PEN)

317.79 +0.24 (+0.08%)

Delayed Quote Updated: 9:57 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Penumbra, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

These stocks are gapping in today's session ↗

January 15, 2026

Via Chartmill

PEN Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Penumbra, Inc. is Fair to Shareholders

January 15, 2026

From Halper Sadeh LLC

Via Business Wire

Penumbra Shares Soar Pre-Market — What Is The Boston Scientific Agreement? ↗

January 15, 2026

Via Stocktwits

1 Healthcare Stock to Keep an Eye On and 2 We Ignore

January 12, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but...

Via StockStory

Topics Stocks

A Look Into Penumbra Inc's Price Over Earnings ↗

November 05, 2025

Via Benzinga

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

3 Cash-Heavy Stocks We Steer Clear Of

January 06, 2026

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

3 Mid-Cap Stocks with Open Questions

January 04, 2026

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract...

Via StockStory

Topics Economy

3 Inflated Stocks We’re Skeptical Of

December 07, 2025

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro...

Via StockStory

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 In Review: Penumbra (NYSE:PEN) Vs Peers

November 25, 2025

Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Penumbra (NYSE:PEN) and its peers.

Via StockStory

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut.

Via StockStory

Topics Economy

1 Cash-Heavy Stock to Consider Right Now and 2 Facing Headwinds

November 16, 2025

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

3 Cash-Producing Stocks We Steer Clear Of

November 12, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

2 Healthcare Stocks to Keep an Eye On and 1 We Find Risky

November 11, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

Here's How Much $1000 Invested In Penumbra 10 Years Ago Would Be Worth Today ↗

November 11, 2025

Via Benzinga

Looking Into Penumbra Inc's Recent Short Interest ↗

November 11, 2025

Via Benzinga

Expedia, Sandisk and Penumbra Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 3-Nov. 7): Are the Others in Your Portfolio? ↗

November 09, 2025

Expedia, SanDisk, and Penumbra led last week's large-cap gainers, with strong earnings and raised guidance fueling broad double-digit jumps.

Via Benzinga

Datadog, Fastly, Planet Fitness, Air Products And Other Big Stocks Moving Higher On Thursday ↗

November 06, 2025

Via Benzinga

Penumbra (PEN) Q3 2025 Earnings Call Transcript ↗

November 06, 2025

Penumbra (PEN) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Why Penumbra (PEN) Stock Is Up Today

November 06, 2025

Shares of medical device company Penumbra (NYSE:PEN) jumped 17.2% in the morning session after it reported third-quarter 2025 financial results that surpassed Wall Street's expectations for both...

Via StockStory

Penumbra Shoots For A Breakout On 'Another Impressive Quarter' ↗

November 06, 2025

There are plenty of catalysts to like for the remainder or 2025 and into 2026, one analyst said.

Via Investor's Business Daily

Penumbra (NYSE:PEN) Delivers Strong Q3 Numbers, Stock Jumps 18.7%

November 05, 2025

Medical device company Penumbra (NYSE:PEN) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 17.8% year on year to $354.7 million. Its non-GAAP profit of $0.97 per...

Via StockStory

Stocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday? ↗

November 05, 2025

Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid solid corporate earnings and growing signs that the Federal Reserve may be nearing...

Via Benzinga

Topics Economy

What To Expect From Penumbra’s (PEN) Q3 Earnings

November 03, 2025

Medical device company Penumbra (NYSE:PEN) will be reporting results this Wednesday after the bell. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Why Penumbra (PEN) Shares Are Falling Today

October 28, 2025

Shares of medical device company Penumbra (NYSE:PEN) fell 5.5% in the afternoon session after the company announced results from its landmark STORM-PE randomized controlled trial. The study found that...

Via StockStory

Topics Artificial Intelligence

Deep Dive Into Penumbra Stock: Analyst Perspectives (13 Ratings) ↗

October 27, 2025

Via Benzinga

Can Penumbra's 'Landmark' Study Vs. Blood Thinners Change Guidelines? ↗

October 26, 2025

Penumbra pitted its device, Lightning Flash, with blood thinners vs. blood thinners, alone, in patients with pulmonary embolism.

Via Investor's Business Daily

Here's How Much You Would Have Made Owning Penumbra Stock In The Last 10 Years ↗

October 24, 2025

Via Benzinga

Penumbra (PEN) Stock Trades Up, Here Is Why

October 08, 2025

Shares of medical device company Penumbra (NYSE:PEN) jumped 3.2% in the morning session after Needham upgraded the stock to 'Buy' from 'Hold' and set a price target of $326.

Via StockStory

Topics World Trade

This Penumbra Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday ↗

October 08, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.